Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene Schiff

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Journal of Clinical Pharmacology|October 28, 2010
Efficacy and pharmacokinetics of adefovir dipivoxil liquid suspension in patients with chronic hepatitis B and renal impairmentMitchell L Shiffman, Stanislas Pol, Lionel Rostaing, et al.
Hepatology (Baltimore, Md.)|April 2, 2003
Durability of serologic response after lamivudine treatment of chronic hepatitis BJules L Dienstag, Janusz Cianciara, Selim Karayalcin, et al.
Hepatology (Baltimore, Md.)|May 8, 2018
Hepatitis B Virus Serum DNA andRNA Levels in Nucleos(t)ide Analog-Treated or Untreated Patients During Chronic and Acute InfectionEmily K Butler, Jeffrey Gersch, Anne McNamara, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 13, 2018
Viral eradication is required for sustained improvement of patient-reported outcomes in patients with hepatitis CZobair M Younossi, Maria Stepanova, Rajender Reddy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2003
Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis BChing-Lung Lai, Jules Dienstag, Eugene Schiff, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 3, 2009
Pharmacokinetics of tacrolimus co-administered with adefovir dipivoxil to liver transplant recipientsNorah A Terrault, Tram T Tran, Eugene Schiff, et al.
Hepatology (Baltimore, Md.)|April 3, 2021
Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 TrialSamer Gawrieh, Mazen Noureddin, Nicole Loo, et al.
Transplantation|November 7, 2007
Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one yearTomoaki Kato, Jeffrey J Gaynor, Hideo Yoshida, et al.
Gastroenterology|December 31, 2003
Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virusRobert Perrillo, Hie-Won Hann, David Mutimer, et al.
The American Journal of Gastroenterology|August 23, 2002
Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver diseaseGuy W Neff, Christopher B O'Brien, K Rajender Reddy, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pharmacology|October 28, 2010
Efficacy and pharmacokinetics of adefovir dipivoxil liquid suspension in patients with chronic hepatitis B and renal impairmentMitchell L Shiffman, Stanislas Pol, Lionel Rostaing, et al.
Hepatology (Baltimore, Md.)|April 2, 2003
Durability of serologic response after lamivudine treatment of chronic hepatitis BJules L Dienstag, Janusz Cianciara, Selim Karayalcin, et al.
Hepatology (Baltimore, Md.)|May 8, 2018
Hepatitis B Virus Serum DNA andRNA Levels in Nucleos(t)ide Analog-Treated or Untreated Patients During Chronic and Acute InfectionEmily K Butler, Jeffrey Gersch, Anne McNamara, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 13, 2018
Viral eradication is required for sustained improvement of patient-reported outcomes in patients with hepatitis CZobair M Younossi, Maria Stepanova, Rajender Reddy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2003
Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis BChing-Lung Lai, Jules Dienstag, Eugene Schiff, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 3, 2009
Pharmacokinetics of tacrolimus co-administered with adefovir dipivoxil to liver transplant recipientsNorah A Terrault, Tram T Tran, Eugene Schiff, et al.
Hepatology (Baltimore, Md.)|April 3, 2021
Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 TrialSamer Gawrieh, Mazen Noureddin, Nicole Loo, et al.
Transplantation|November 7, 2007
Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one yearTomoaki Kato, Jeffrey J Gaynor, Hideo Yoshida, et al.
Gastroenterology|December 31, 2003
Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virusRobert Perrillo, Hie-Won Hann, David Mutimer, et al.
The American Journal of Gastroenterology|August 23, 2002
Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver diseaseGuy W Neff, Christopher B O'Brien, K Rajender Reddy, et al.
Pageof 5